Full-Time

Pharmacist

Full Time

Posted on 9/4/2025

Curaleaf

Curaleaf

1,001-5,000 employees

Cannabis cultivation, processing, and retailing

Compensation Overview

$70/hr

Plattsburgh, NY, USA

In Person

Category
Medical, Clinical & Veterinary (1)
Required Skills
Inventory Management
Requirements
  • An active Pharmacy License in the state you’re applying for.
  • Strong knowledge of the retail and pharmacy landscape.
  • A passion for patient care and the medical cannabis industry.
  • Effective communication skills at all levels inside and outside the organization.
  • Outstanding customer service skills, with the ability to address concerns professionally.
  • Flexibility with scheduling, able to work nights, weekends, and holidays as needed.
Responsibilities
  • Provide patients with accurate product recommendations, dosing, consumption methods, and product details.
  • Assist patients with questions, concerns, and complaints, adjusting recommendations and/or dosing based on patient feedback.
  • Train team members on product knowledge, ensuring they provide proper recommendations to patients.
  • Build and maintain relationships with physicians, patients, politicians, and professionals in the community.
  • Deepen your understanding of cannabis products, dosing, drug interactions, side effects, and the efficacy of different strains and delivery methods.
  • Ensure compliance with company policies, procedures, and all federal and state laws. Oversee inventory audits and dispensing operations.
  • Assist with inventory forecasting, product intake, and maintaining systems for regulatory reporting and sales analysis.

Curaleaf is a cannabis company that grows, processes, and sells cannabis products for medical and recreational use. It offers items such as tinctures, flowers, and edibles, and uses encapsulation technology to improve product absorption and effectiveness. Customers can buy at dispensaries or online, and the company also provides medical consultations and guidance services. Differentiators include its vertically integrated model (cultivation, processing, and retail) and its social responsibility efforts, such as the B NOBLE program that supports individuals with cannabis-related non-violent charges. The company’s goal is to provide reliable cannabis products and related services to a wide range of customers while advancing responsible access and advocacy through programs like B NOBLE.

Company Size

1,001-5,000

Company Stage

IPO

Headquarters

Wakefield, Massachusetts

Founded

2010

Simplify Jobs

Simplify's Take

What believers are saying

  • Germany adult-use rollout drives Four 20 Pharma revenue growth.
  • Florida dispensaries expand to 73 locations boosting medical sales.
  • European network connects Portugal cultivation to German pharmacies.

What critics are saying

  • Aurora Cannabis captures 15% German share via low-price imports.
  • Green Thumb forces Curaleaf Florida price cuts with 90 dispensaries.
  • Illicit vapes slash Select Briq sales 30% in key states.

What makes Curaleaf unique

  • Curaleaf controls 4.2 million square feet of cultivation across US facilities.
  • Four 20 Pharma offers EU-GMP certified production in Germany since 2020.
  • Select Briq 2 vape features encapsulation for better absorption.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Paid Vacation

Parental Leave

401(k) Retirement Plan

Life Insurance

Disability Insurance

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

0%

2 year growth

0%
Curaleaf Holdings, Inc.
May 2nd, 2026
Curaleaf Completes Majority Stake Acquisition of Germany's Four 20 Pharma

Deal Solidifies Curaleaf's Strategic Advantage in Germany as the Country Prepares for Adult-Use WAKEFIELD, Mass., Sept. 19, 2022 /PRNewswire/ -- Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF)...

Yahoo Finance
Apr 6th, 2026
Curaleaf expands US retail footprint and launches Select Briq 2 vape amid softer FDA CBD stance

Curaleaf Holdings has expanded its retail presence with new dispensaries in Lorain, Ohio and Cape Coral, Florida, whilst launching its Select Briq 2 vape device across US medical and adult-use markets. The company has also extended its executive automatic securities disposition plan. The developments come as the FDA adopts a softer stance on certain CBD regulations, potentially reshaping Curaleaf's international expansion strategy. The Select Briq 2 launch represents a push towards differentiated hardware and branded products aimed at higher margins. However, the cannabis company faces ongoing challenges including sustained price compression, high operating costs and US$500 million in debt. Analysts project US$1.5 billion revenue and a swing to positive earnings by 2028, though significant uncertainty remains around regulatory developments and pricing pressures.

PR Newswire
Mar 31st, 2026
Curaleaf opens 164th dispensary in Lorain, Ohio in partnership with RC Retail

Curaleaf Holdings has opened a new branded dispensary in Lorain, Ohio, marking its 164th retail location nationwide. The company provides support services to current owner and operator RC Retail, with future rights to ownership pending regulatory approval. Located at 2507 West Erie Avenue, the dispensary serves both medical patients and adult-use customers. It stocks premium cannabis products including Select BRIQ vapes, Find flower and Grassroots flower. The store operates Monday to Saturday from 9:00 to 20:00, and Sundays from 9:00 to 19:00. A grand opening celebration is scheduled for 10 April, featuring discounts through 20 April. Curaleaf now operates six locations in Ohio, including stores in Cuyahoga Falls, Findlay, Girard, Lima and Newark.

Yahoo Finance
Mar 27th, 2026
Curaleaf shares drop 21% in 3 months despite 110% yearly gains as analysts see 39% upside

Curaleaf Holdings closed at CA$2.98, down 6% over the past week and 12% over the past month, despite a one-year total return of 110%. The cannabis company's shares have declined 21% over three months. The most popular valuation narrative suggests Curaleaf is 39.2% undervalued, with a fair value estimate of CA$4.90. The company is expanding internationally, showing strong sequential and yearly growth in Germany and entering Turkey's 87-million-person market. It recently launched the first medically certified EU device. Analysts believe international expansion will diversify revenue streams beyond the saturated US market and drive long-term growth. However, investors face risks including regulatory uncertainty and costs associated with entering early-stage international markets.

PR Newswire
Feb 25th, 2026
Curaleaf opens fifth Ohio dispensary in Findlay, expanding US retail footprint to 162 locations

Curaleaf Holdings has opened its fifth dispensary in Ohio, located in Findlay at 2205 Tiffin Avenue, bringing its nationwide retail count to 162 locations. The store will serve both medical patients and adult-use customers across Northwest Ohio. The dispensary offers a range of cannabis products including Select BRIQ all-in-one vape, Find and Grassroots flower. Located in a retail and dining hub, Curaleaf Findlay operates from 9:00 AM to 8:00 PM Monday through Saturday and 9:00 AM to 7:00 PM on Sundays. Curaleaf currently operates Ohio locations in Cuyahoga Falls, Findlay, Girard, Lima and Newark. The company is listed on the Toronto Stock Exchange under the symbol CURA and trades on the OTCQX market under CURLF.

INACTIVE